CLBCX
Price
$39.01
Change
+$0.06 (+0.15%)
Updated
Oct 6 closing price
Net Assets
265.73B
TSHIX
Price
$15.97
Change
+$0.02 (+0.13%)
Updated
Oct 6 closing price
Net Assets
830.41M
Interact to see
Advertisement

CLBCX vs TSHIX

Header iconCLBCX vs TSHIX Comparison
Open Charts CLBCX vs TSHIXBanner chart's image
American Funds American Balanced 529C
Price$39.01
Change+$0.06 (+0.15%)
VolumeN/A
Net Assets265.73B
Transamerica Multi-Asset Income I
Price$15.97
Change+$0.02 (+0.13%)
VolumeN/A
Net Assets830.41M
CLBCX vs TSHIX Comparison Chart in %
View a ticker or compare two or three
VS
CLBCX vs. TSHIX commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLBCX is a Buy and TSHIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CLBCX has more cash in the bank: 266B vs. TSHIX (830M). TSHIX pays higher dividends than CLBCX: TSHIX (3.46) vs CLBCX (1.06). CLBCX was incepted earlier than TSHIX: CLBCX (24 years) vs TSHIX (12 years). CLBCX (1.35) is less costly to investors than TSHIX (0.73). CLBCX (44.00) and TSHIX (42.00) have comparable annual turnover. CLBCX has a lower initial minimum investment than TSHIX: CLBCX (250) vs TSHIX (1000000). TSHIX annual gain was more profitable for investors over the last year : 14.23 vs. CLBCX (8.79). TSHIX return over 5 years is better than : 60.38 vs. CLBCX (40.13).
CLBCXTSHIXCLBCX / TSHIX
Total Expense Ratio1.350.72188%
Annual Report Gross Expense Ratio1.350.73185%
Fund Existence24 years12 years-
Gain YTD14.02913.036108%
Front LoadN/AN/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets266B830M32,048%
Annual Yield % from dividends1.063.4631%
Returns for 1 year8.7914.2362%
Returns for 3 years48.8348.88100%
Returns for 5 years40.1360.3866%
Returns for 10 years75.88117.0765%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EMX5.310.34
+6.84%
EMX Royalty Corp
SMMT22.150.72
+3.36%
Summit Therapeutics
TUSK2.30N/A
N/A
Mammoth Energy Services
HURN150.20-0.12
-0.08%
Huron Consulting Group
APRE1.49-0.02
-1.00%
Aprea Therapeutics